A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

about

Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.

P2860

Q41677197-D103D78B-226B-4E1C-A394-F762A4EDA7E0

P2860

A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

Item

http://www.wikidata.org/entity/Q39002421

description

2016 nî lūn-bûn

@nan

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

name

A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

@en

A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

@nl

type

Item

label

A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

@en

A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

@nl

prefLabel

A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

@en

A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

@nl

P1476

A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

@en

P2093

Jorge Alsina

http://www.w3.org/2001/XMLSchema#string

Raul Alsina

http://www.w3.org/2001/XMLSchema#string

Seza Gulec

http://www.w3.org/2001/XMLSchema#string

P2860

An overview of the c-MET signaling pathway

RAS mutations in thyroid cancer

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.

A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma

Pax-8-PPAR-γ fusion protein in thyroid carcinoma

Integrated genomic characterization of papillary thyroid carcinoma

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

TRKing down an old oncogene in a new era of targeted therapy

Enhancement of sodium/iodide symporter expression in thyroid and breast cancer

The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer

P304

102-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4274/2017.26.SUPPL.12

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28117295

http://www.w3.org/2001/XMLSchema#string

P932

5283709

http://www.w3.org/2001/XMLSchema#string

A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

about

P2860

P2860

A Concise Atlas of Thyroid Cancer Next-Generation Sequencing Panel ThyroSeq v.2.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932